Previous close | 171.90 |
Open | 172.35 |
Bid | 172.40 x 6700 |
Ask | 172.45 x 11200 |
Day's range | 171.85 - 172.75 |
52-week range | 134.30 - 173.10 |
Volume | |
Avg. volume | 272,122 |
Market cap | 74.977B |
Beta (5Y monthly) | 0.68 |
PE ratio (TTM) | 27.55 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.20 (1.28%) |
Ex-dividend date | 29 Apr 2024 |
1y target est | N/A |
Merck KGaA (MKGAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Merck KGaA (MKGAF) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Key Insights The projected fair value for Merck KGaA is €236 based on 2 Stage Free Cash Flow to Equity Merck KGaA's...